Cerebral amyloid angiopathy with focal presentation-about 3 cases.

Cerebral amyloid angiopathy (CAA) is a common cerebrovascular disease involved in ischemic and hemorrhagic strokes, and its progression is correlated to cognitive decline. In vivo diagnosis of CAA is guided by the modified Boston criteria, with the presence of multiple intracerebral hemorrhage or cerebral microbleeds (CMB), or single hemorrhage and cortical superficial siderosis. The diagnosis of CAA is highly dependent on the quality of imaging and the advent of susceptibility-weighted imaging (SWI) sequences has improved sensitivity of MRI to detect hemosiderin deposition and CMB, hallmarks of CAA.

Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years.

Background: There is evidence that adipokines have roles in brain functioning and cognitive decline.

Objective: Assess the role of leptin and adiponectin levels in predicting changes in neuro-cognitive disorders (NCD).

Methods: The study included 205 patients over 65 years of age presenting for a one-day hospitalization for current assessment of cognitive function.

Adding methylphenidate to prism-adaptation improves outcome in neglect patients. A randomized clinical trial.

Unlabelled: Spatial neglect is one of the main predictors of poor functional recovery after stroke. Many therapeutic interventions have been developed to alleviate this condition, but to date the evidence of their effectiveness is still scarce.

Objective: The purpose of this study was to test whether combining prism adaptation (PA) and methylphenidate (MP) could enhance the recovery of neglect patients at a functional level.